Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia

BACKGROUND: The most advanced dengue vaccine candidate is a live-attenuated recombinant vaccine containing the four dengue viruses on the yellow fever vaccine backbone (CYD-TDV) developed by Sanofi Pasteur. Several analyses have been published on the safety and immunogenicity of the CYD-TDV vaccine...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Vaccine
Päätekijät: Dorigatti, Ilaria, Aguas, Ricardo, Donnelly, Christl A., Guy, Bruno, Coudeville, Laurent, Jackson, Nicholas, Saville, Melanie, Ferguson, Neil M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier Science 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4504002/
https://ncbi.nlm.nih.gov/pubmed/26051515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.05.059
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia